March 6, 2012

AmerisourceBergen on Tuesday announced that it has signed a definitive agreement to purchase World Courier Group, a privately held global specialty transportation and logistics provider for the biopharmaceutical industry, for $520 million in cash.

September 7, 2011

A specialty biopharmaceutical company has elected two members to its board of directors.

September 1, 2011

After entering a definitive agreement to acquire biopharmaceutical company Icagen, Pfizer has extended its tender offer for all outstanding shares of common stock.

August 30, 2011

The VP strategic alliances and partnerships for Pfizer's oncology division has joined the corporate advisory board at a development-stage oncology and dermatology biopharmaceutical company.

July 28, 2011

Pfizer has entered a definitive agreement to acquire a biopharmaceutical company that focuses on the development of pain treatments.

April 27, 2011

A biopharmaceutical company has appointed a new CFO.

March 30, 2011

A biopharmaceutical company that specializes in diabetes treatments has appointed a new board chairman.

March 9, 2011

Eli Lilly leader John Lechleiter has become something of an evangelist for medical innovation lately. On Wednesday, the Lilly chairman, president and CEO spoke to the U.S./Japan Business Council in Tokyo to call for changes and policies in the biopharmaceutical industry that encourage innovation, or “reinventing invention,” as he called it.

February 2, 2011

A new report developed by the Pharmaceutical Research and Manufacturers of America revealed that nearly 300 heart disease and stroke medicines are in development.

January 25, 2011

John Johnson is bidding Eli Lilly adieu.

December 21, 2010

Abbott has made a pact with a biopharmaceutical company to develop new cancer treatments by making small-molecule inhibitors.

December 21, 2010

A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.

December 6, 2010

Pfizer president and CEO Jeffrey Kindler has retired from the company, the drug maker said Sunday. Ian Read, who currently heads Pfizer’s global biopharmaceutical operations and has worked for the company since 1978, will succeed him.

November 15, 2010

Biopharmaceutical company Oragenics has expanded retail distribution of its oral care probiotic EvoraPlus through an...

September 19, 2010

Oragenics, a biopharmaceutical company, has announced that its oral care probiotics line, EvoraPlus, will be...

September 7, 2010

Swiss drug maker Lonza will help British drug maker GlaxoSmithKline manufacture five biotech drugs in...

August 31, 2010

A specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes...

August 31, 2010

Eli Lilly's method-of-use patents for its osteoporosis drug were declared valid by a federal court...

July 14, 2010

Watson Pharmaceuticals will work with a venture-backed firm to develop a biosimilar treatment for female...

May 9, 2010

U.S. biotechnology company Genentech and German drug maker Evotec hope to develop drugs using Evotec’s...

March 12, 2009

The long-awaited breakthrough for follow-on biologics may be close at hand....